Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-03

Clinical Trial Update: Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy [NA]

View source ↗

Summary

This clinical trial update shows that the hyperbaric oxygen study for carbon monoxide–induced chronic encephalopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Carbon Monoxide Poisoning, Chronic Encephalopathy | NA | Status: WITHDRAWN